Emily Lau, MD, is a member of the class of 2021 in the Cardiovascular Disease Fellowship Program at Massachusetts General Hospital. Dr. Lau shares what drew her to Mass General, the culture of the program and her experience as a trainee during the COVID-19 pandemic.
Explore This Treatment Program
Treatment for hypertension at Massachusetts General Hospital is a specialized medical service for patients who have elevated blood pressure. Specialists evaluate newly diagnosed patients who have not yet been treated, patients who have already been diagnosed, but have trouble controlling their high blood pressure, and patients who have not tolerated traditional therapy. These patients may refer themselves to the service or be referred by their primary care physician or specialist.
Treatment for hypertension emphasizes a multidisciplinary approach to blood pressure control. The treatment regimen might include anti-hypertensive drug therapy and lifestyle modifications such as exercise, weight loss, diet modification, smoking cessation and stress reduction. Many patients also have other conditions such as high cholesterol, diabetes, cardiac arrhythmias, coronary artery disease, angina pectoris or other disorders that might affect the treatment regimen. Specialists are able to treat these patients with individualized therapies that control blood pressure elevation without side effects or disrupting their lifestyles.
Our services also maintain a close relationship with the Benson-Henry Institute for Mind-Body Medicine and use their program for stress management and relaxation response services that facilitate blood pressure control.
Research & Clinical Trials
Hypertension specialists are involved in numerous clinical research protocols for patients with high blood pressure, as well as high cholesterol, diabetes, coronary artery disease, myocardial infarction (heart attack) and atrial fibrillation. Patients benefit from our involvement in innovative research because they have access to the latest therapies and treatment information.
We are currently seeking participants for the following clinical trials:
Mass General is dedicated to ensuring that people understand their health care choices and have the necessary information to make decisions affecting their health and wellbeing. The related support and wellness information listed below can play a role in treatment options.
- Press Release
- Aug | 25 | 2020
Massachusetts General Hospital first in New England to perform new procedures for tricuspid valve disease
Massachusetts General Hospital (MGH) is announcing two first-of-their-kind procedures in New England today, to treat one of the most common forms of heart valve disease.
- Press Release
- Aug | 19 | 2020
Clinical and sociodemographic features of early COVID-19 patients in Massachusetts: MGH study suggests vulnerable populations are hardest hit
Data from the first COVID-19 patients treated at three large Massachusetts hospitals reveal important trends, including disproportionate representation of vulnerable populations, high rates of disease-related complications, and the need for post-discharge, post-acute care and monitoring.
- Jun | 23 | 2020
As the initial surge of the COVID-19 pandemic subsides, Massachusetts General Hospital leaders are discussing the transition to strategies for recovery and wellness.
- Press Release
- Jun | 2 | 2020
A team led by investigators at Mass General and the Broad Institute of MIT and Harvard recently found that applying “polygenic risk scores” can identify at-risk patients who are not presently identified through standard clinical evaluations.
- Patient Education
- May | 27 | 2020
During the COVID-19 pandemic, the Mass General Corrigan Minehan Heart Center is providing general and surgical care for our patients. We have taken unprecedented steps to ensure all office visits, procedures and surgeries are welcoming and safe. We have also expanded our virtual visit offerings.